Citation:Speicher PJ, Gu L, Wang X, Hartwig MG, D'Amico TA, Berry MF 2015

From Cancer Guidelines Wiki

Citation


Speicher PJ, Gu L, Wang X, Hartwig MG, D'Amico TA, Berry MF. Adjuvant Chemotherapy After Lobectomy for T1-2N0 Non-Small Cell Lung Cancer: Are the Guidelines Supported? J Natl Compr Canc Netw 2015 Jun;13(6):755-61 Available from: http://www.ncbi.nlm.nih.gov/pubmed/26085391.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
Speicher PJ, Gu L, Wang X, Hartwig MG, D'Amico TA, Berry MF 2015What is the role of chemotherapy after surgery in the treatment of operable stage I NSCLC?Associate Professor Christos Karapetiscompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:What is the role of chemotherapy after surgery in the treatment of operable stage I NSCLC?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the role of chemotherapy after surgery in the treatment of operable stage I NSCLC?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. What is the role of chemotherapy after surgery in the treatment of operable stage I NSCLC?
Retrieved from "https://wiki.cancer.org.au/australiawiki/index.php?title=Citation:Speicher_PJ,_Gu_L,_Wang_X,_Hartwig_MG,_D%27Amico_TA,_Berry_MF_2015&oldid=131318"